May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Deposition of Advanced Glycation End Products in Climatic Droplet Keratopathy
Author Affiliations & Notes
  • Y. Kaji
    Ophthalmology, Universityof Tsukuba Institute of Clinical Medicine, Ibaraki, Japan
  • S. Amano
    Ophthalmology,
    Universityof Tokyo Graduate School of Medicine, Tokyo, Japan
  • R. Nagai
    Medical Biochemistry, , Graduate School of Medical and Pharmaceutical Sciences, Kumamoto, Japan
  • Y. Takazawa
    Pathology,
    Universityof Tokyo Graduate School of Medicine, Tokyo, Japan
  • M. Fukayama
    Pathology,
    Universityof Tokyo Graduate School of Medicine, Tokyo, Japan
  • T. Oshika
    Ophthalmology, Universityof Tsukuba Institute of Clinical Medicine, Ibaraki, Japan
  • Footnotes
    Commercial Relationships  Y. Kaji, None; S. Amano, None; R. Nagai, None; Y. Takazawa, None; M. Fukayama, None; T. Oshika, None.
  • Footnotes
    Support  Ministry of Education, Science, Sports and Culture, Grant–in–Aid for Young Scientists, 16791042 in Japan
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 1649. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y. Kaji, S. Amano, R. Nagai, Y. Takazawa, M. Fukayama, T. Oshika; Deposition of Advanced Glycation End Products in Climatic Droplet Keratopathy . Invest. Ophthalmol. Vis. Sci. 2006;47(13):1649.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Climatic droplet keratopathy (CDK) is a common disease especially in equatoward and subarctic areas. However, the nature of the depositions in CDK is still unclear. To reveal the mechanism of the development of CDK, we investigated the immunohistochemical localization of advanced glycation end products (AGEs) in the surgical specimens of CDK.

Methods: : We investigated corneas with CDK (n = 3), bullous keratopathy (n = 4), band keratopathy (n = 3), and corneas without any diseases (n = 4). Monoclonal antibodies to Nε–(carboxy)methyl–L–lysine (CML), pentosidine, and pyrraline were prepared. Immunohistochemical localization of AGEs was investigated using the above antibodies and streptavidin–biotin method. The immunohistochemistry was carried out triplicate.

Results: : Strong immunoreactivities to CML and pentosidine and weak immunoreactivity to pyrraline were detected in the subepithelial deposits in all specimens with CDK. In contrast, no immunoreactivities to CML, pentosidine, or pyrraline were detected in corneas with bullous keratopathy, spheroid degeneration, and control corneas.

Conclusions: : Deposition of advanced glycation end products is a cause of climatic droplet keratopathy. In this sense, protection against ultraviolet ray, one of the accelerators of AGEs formation, would be an effective measure to prevent CDK.

Keywords: cornea: basic science • degenerations/dystrophies • glycoconjugates/glycoproteins 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×